Literature DB >> 30920725

African swine fever: Update on Eastern, Central and Southern Africa.

Léopold K Mulumba-Mfumu1,2, Claude Saegerman2, Linda K Dixon3, Kapanga C Madimba1, Eric Kazadi1, Ndeji T Mukalakata1, Chris A L Oura4, Erika Chenais5, Charles Masembe6, Karl Ståhl5, Etienne Thiry7, Mary Louise Penrith8.   

Abstract

Control of African swine fever (ASF) in countries in Eastern, Central and Southern Africa (ECSA) is particularly complex owing to the presence of all three known epidemiological cycles of maintenance of the virus, namely an ancient sylvatic cycle involving the natural hosts and vectors of the disease as well as domestic cycles with and without involvement of natural vectors. While the situation is well documented in some of the countries, for others very little information is available. In spite of the unfavourable ASF situation, the pig population in the sub-region has grown exponentially in recent decades and is likely to continue to grow in response to rapid urban growth resulting in increasing demand for animal protein by populations that are no longer engaged in livestock production. Better management of ASF will be essential to permit the pig sector to reach its full potential as a supplier of high quality protein and a source of income to improve livelihoods and create wealth. No vaccine is currently available and it is likely that, in the near future, the sub-region will continue to rely on the implementation of preventive measures, based on the epidemiology of the disease, to avoid both the devastating losses that outbreaks can cause and the risk the sub-region poses to other parts of Africa and the world. The current situation in the ECSA sub-region is reviewed and gaps in knowledge are identified in order to support ongoing strategy development for managing ASF in endemic areas.
© 2019 Blackwell Verlag GmbH.

Entities:  

Keywords:  African swine fever; Central Africa; Eastern Africa; Southern Africa; epidemiology; knowledge gaps; management; pig production; socio-economic impact

Mesh:

Year:  2019        PMID: 30920725     DOI: 10.1111/tbed.13187

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  27 in total

1.  African swine fever in the northern regions of Cameroon: seroprevalence survey and spatiotemporal analysis of outbreaks from 2010 to 2017.

Authors:  Mohamed Moctar Mouliom Mouiche; Ranyl Nguena Guefack Noumedem; Rodrigue Poueme Namegni; Jean Marc Kameni Feussom; Frédéric Moffo; Ndode Herman Okah-Nnane; Hermann Landry Munshili Njifon; Abel Wade; Julius Awah-Ndukum
Journal:  Trop Anim Health Prod       Date:  2021-03-19       Impact factor: 1.559

2.  Scientific Opinion on the assessment of the control measures of the category A diseases of Animal Health Law: African Swine Fever.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Klaus Depner; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Paolo Pasquali; Helen Clare Roberts; Liisa Helena Sihvonen; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Kris De Clercq; Eyal Klement; Jan Arend Stegeman; Simon Gubbins; Sotiria-Eleni Antoniou; Alessandro Broglia; Yves Van der Stede; Gabriele Zancanaro; Inma Aznar
Journal:  EFSA J       Date:  2021-01-31

3.  Risk factors of African swine fever virus in suspected infected pigs in smallholder farming systems in South-Kivu province, Democratic Republic of Congo.

Authors:  Patrick N Bisimwa; Michel Dione; Bisimwa Basengere; Ciza Arsène Mushagalusa; Lucilla Steinaa; Juliette Ongus
Journal:  J Vet Sci       Date:  2021-05       Impact factor: 1.672

4.  FoxJ1 inhibits African swine fever virus replication and viral S273R protein decreases the expression of FoxJ1 to impair its antiviral effect.

Authors:  Caina Ma; Shasha Li; Fan Yang; Weijun Cao; Huisheng Liu; Tao Feng; Keshan Zhang; Zixiang Zhu; Xiangtao Liu; Yonghao Hu; Haixue Zheng
Journal:  Virol Sin       Date:  2022-05-02       Impact factor: 6.947

Review 5.  An Update on African Swine Fever Virology.

Authors:  Axel Karger; Daniel Pérez-Núñez; Jesús Urquiza; Patricia Hinojar; Covadonga Alonso; Ferdinando B Freitas; Yolanda Revilla; Marie-Frédérique Le Potier; Maria Montoya
Journal:  Viruses       Date:  2019-09-17       Impact factor: 5.048

6.  First detection of African swine fever (ASF) virus genotype X and serogroup 7 in symptomatic pigs in the Democratic Republic of Congo.

Authors:  Patrick N Bisimwa; Juliette R Ongus; Christian K Tiambo; Eunice M Machuka; Espoir B Bisimwa; Lucilla Steinaa; Roger Pelle
Journal:  Virol J       Date:  2020-09-03       Impact factor: 4.099

7.  Substitution of warthog NF-κB motifs into RELA of domestic pigs is not sufficient to confer resilience to African swine fever virus.

Authors:  Stephen McCleary; Rebecca Strong; Ronan R McCarthy; Jane C Edwards; Emma L Howes; Lisa M Stevens; Pedro J Sánchez-Cordón; Alejandro Núñez; Samantha Watson; Alan J Mileham; Simon G Lillico; Christine Tait-Burkard; Chris Proudfoot; Maeve Ballantyne; C Bruce A Whitelaw; Falko Steinbach; Helen R Crooke
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

Review 8.  Putative Role of Arthropod Vectors in African Swine Fever Virus Transmission in Relation to Their Bio-Ecological Properties.

Authors:  Sarah I Bonnet; Emilie Bouhsira; Nick De Regge; Johanna Fite; Florence Etoré; Mutien-Marie Garigliany; Ferran Jori; Laetitia Lempereur; Marie-Frédérique Le Potier; Elsa Quillery; Claude Saegerman; Timothée Vergne; Laurence Vial
Journal:  Viruses       Date:  2020-07-20       Impact factor: 5.048

9.  Genetic profile of African swine fever virus responsible for the 2019 outbreak in northern Malawi.

Authors:  J N Hakizimana; G Kamwendo; J L C Chulu; O Kamana; H J Nauwynck; G Misinzo
Journal:  BMC Vet Res       Date:  2020-08-28       Impact factor: 2.741

10.  Mathematical Approach to Estimating the Main Epidemiological Parameters of African Swine Fever in Wild Boar.

Authors:  Federica Loi; Stefano Cappai; Alberto Laddomada; Francesco Feliziani; Annalisa Oggiano; Giulia Franzoni; Sandro Rolesu; Vittorio Guberti
Journal:  Vaccines (Basel)       Date:  2020-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.